Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2021 Filed Mar 24, 2021 01:32 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001631 · form4-03232021_060352.xml · derivative · entry 3 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F2 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing 03/19/2022. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:30 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001630 · form4-03232021_060316.xml · derivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F1 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:28 UTC |
Parra Raul Jr.CFO AND TREASURER
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001629 · form4-03232021_060339.xml · derivative · entry 3 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F2 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:26 UTC |
Voigt Michel J.CHIEF HUMAN RESOURCES OFFICER
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001628 · form4-03232021_060341.xml · derivative · entry 1 Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F1 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 22:18 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
SaleCommon Stock, No Par Value | 5,000 | $60.60 | $303,000.00 |
DisclosureSEC source: 0001415889-21-001576 · form4-03182021_030313.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:34 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
SaleCommon Stock, No Par Value | 2,115 | $58.72 | $124,192.80 |
DisclosureSEC source: 0001415889-21-001524 · form4-03162021_060322.xml · nonDerivative · entry 3 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,039 Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 22:52 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,246 | $0.00 Strike: $21.98 | $0.00 |
DisclosureSEC source: 0001415889-21-001555 · form4-03172021_030342.xml · derivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,246 shares Expires 2022-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In the Reporting Person's Form 4 filed on June 24, 2020, the number of these options was incorrectly listed at 4,264 when the correct number of options was 4,246. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 07/16/2016. F1 · derivative.underlying_shares: In the Reporting Person's Form 4 filed on June 24, 2020, the number of these options was incorrectly listed at 4,264 when the correct number of options was 4,246. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 22:52 UTC |
Millner F. Ann Ed.D.Director
|
Tax withholdingCommon Stock, No Par Value | 1,552 | $60.15 | $93,352.80 |
DisclosureSEC source: 0001415889-21-001555 · form4-03172021_030342.xml · nonDerivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,924 Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 22:52 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 4,246 | $21.98 | $93,327.08 |
DisclosureSEC source: 0001415889-21-001555 · form4-03172021_030342.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:37 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
SaleCommon Stock, No Par Value | 4,947 | $59.60 | $294,841.20 |
DisclosureSEC source: 0001415889-21-001528 · form4-03162021_060306.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,916 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $59.63, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:36 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-001526 · form4-03162021_060357.xml · derivative · entry 4 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 10/04/2015. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:36 UTC |
Parra Raul Jr.CFO AND TREASURER
|
SaleCommon Stock, No Par Value | 1,000 | $59.57 | $59,570.00 |
DisclosureSEC source: 0001415889-21-001526 · form4-03162021_060357.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.64 to $59.55, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:36 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $12.06 | $12,060.00 |
DisclosureSEC source: 0001415889-21-001526 · form4-03162021_060357.xml · nonDerivative · entry 1 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:34 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001415889-21-001524 · form4-03162021_060322.xml · derivative · entry 4 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 25,000 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:34 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
SaleCommon Stock, No Par Value | 12,303 | $59.50 | $732,028.50 |
DisclosureSEC source: 0001415889-21-001524 · form4-03162021_060322.xml · nonDerivative · entry 2 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,154 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $59.58, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:34 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $19.72 | $394,400.00 |
DisclosureSEC source: 0001415889-21-001524 · form4-03162021_060322.xml · nonDerivative · entry 1 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:32 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-001522 · form4-03162021_060327.xml · derivative · entry 5 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:32 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-001522 · form4-03162021_060327.xml · derivative · entry 4 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:32 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
SaleCommon Stock, No Par Value | 25,000 | $59.58 | $1,489,500.00 |
DisclosureSEC source: 0001415889-21-001522 · form4-03162021_060327.xml · nonDerivative · entry 3 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.945 to $59.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:32 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $17.27 | $345,400.00 |
DisclosureSEC source: 0001415889-21-001522 · form4-03162021_060327.xml · nonDerivative · entry 2 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:32 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $12.06 | $60,300.00 |
DisclosureSEC source: 0001415889-21-001522 · form4-03162021_060327.xml · nonDerivative · entry 1 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-001520 · form4-03162021_060356.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 10/04/2015. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
SaleCommon Stock, No Par Value | 25,000 | $59.58 | $1,489,500.00 |
DisclosureSEC source: 0001415889-21-001520 · form4-03162021_060356.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.93 to $59.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock, No Par Value | 25,000 | $12.06 | $301,500.00 |
DisclosureSEC source: 0001415889-21-001520 · form4-03162021_060356.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:32 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
Tax withholdingCommon Stock, No Par Value | 3,893 | $55.72 | $216,917.96 |
DisclosureSEC source: 0001415889-21-001181 · form4-03022021_030350.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972,863 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:32 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
GrantCommon Stock, No Par Value | 8,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001181 · form4-03022021_030350.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,756 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:17 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock, No Par Value | 972 | $55.72 | $54,159.84 |
DisclosureSEC source: 0001415889-21-001203 · form4-03022021_040347.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:17 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
GrantCommon Stock, No Par Value | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001203 · form4-03022021_040347.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,315 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:28 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
Tax withholdingCommon Stock, No Par Value | 972 | $55.72 | $54,159.84 |
DisclosureSEC source: 0001415889-21-001176 · form4-03022021_030315.xml · nonDerivative · entry 2 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:28 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
GrantCommon Stock, No Par Value | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001176 · form4-03022021_030315.xml · nonDerivative · entry 1 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,315 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:26 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Tax withholdingCommon Stock, No Par Value | 972 | $55.72 | $54,159.84 |
DisclosureSEC source: 0001415889-21-001173 · form4-03022021_030301.xml · nonDerivative · entry 2 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,457 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:26 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GrantCommon Stock, No Par Value | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001173 · form4-03022021_030301.xml · nonDerivative · entry 1 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,429 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:24 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Tax withholdingCommon Stock, No Par Value | 972 | $55.72 | $54,159.84 |
DisclosureSEC source: 0001415889-21-001169 · form4-03022021_030313.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,343 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:24 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
GrantCommon Stock, No Par Value | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001169 · form4-03022021_030313.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,315 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:18 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Tax withholdingCommon Stock, No Par Value | 972 | $55.72 | $54,159.84 |
DisclosureSEC source: 0001415889-21-001164 · form4-03022021_030315.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:18 UTC |
Parra Raul Jr.CFO AND TREASURER
|
GrantCommon Stock, No Par Value | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001164 · form4-03022021_030315.xml · nonDerivative · entry 1 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,315 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 19:25 UTC |
Floyd DavidDirector
|
PurchaseCommon Stock, No Par Value | 1,159 | $43.11 | $49,967.39 |
DisclosureSEC source: 0001415889-20-002052 · form4-08062020_120849.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · David & Lisa Floyd Family LP Disclosed balance after: 1,584 Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 01:02 UTC |
Anderson JillDirector
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001709 · form4-06242020_060644.xml · derivative · entry 1 Anderson Jill · CIK 0001764314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:59 UTC |
Hogan James T.Director
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001706 · form4-06242020_050626.xml · derivative · entry 1 Hogan James T. · CIK 0001816127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:57 UTC |
Gunderson Thomas J.Director
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001704 · form4-06242020_050656.xml · derivative · entry 1 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:53 UTC |
Millner F. Ann Ed.D.Director
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001701 · form4-06242020_050624.xml · derivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:52 UTC |
ANDERSON A SCOTTDirector
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001698 · form4-06242020_050600.xml · derivative · entry 2 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:47 UTC |
Ward Lynne N.Director
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001694 · form4-06242020_050625.xml · derivative · entry 1 Ward Lynne · CIK 0001786127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:41 UTC |
Floyd DavidDirector
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001691 · form4-06242020_050621.xml · derivative · entry 2 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:40 UTC |
Carpenter Lonny J.Director
|
GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001689 · form4-06242020_050655.xml · derivative · entry 2 Carpenter Lonny J · CIK 0001451534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:28 UTC |
LIU DAVID MING-TEHDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001415889-20-001489 · form4-06032020_020658.xml · derivative · entry 5 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,500 shares Expires 2024-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:28 UTC |
LIU DAVID MING-TEHDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 6,300 | $0.00 Strike: $21.71 | $0.00 |
DisclosureSEC source: 0001415889-20-001489 · form4-06032020_020658.xml · derivative · entry 4 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 6,300 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 07/25/2017. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:28 UTC |
LIU DAVID MING-TEHDirector
|
SaleCommon Stock, No Par Value | 13,800 | $45.00 | $621,000.00 |
DisclosureSEC source: 0001415889-20-001489 · form4-06032020_020658.xml · nonDerivative · entry 3 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:28 UTC |
LIU DAVID MING-TEHDirector
|
Exercise / conversionCommon Stock, No Par Value | 7,500 | $34.40 | $258,000.00 |
DisclosureSEC source: 0001415889-20-001489 · form4-06032020_020658.xml · nonDerivative · entry 2 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:28 UTC |
LIU DAVID MING-TEHDirector
|
Exercise / conversionCommon Stock, No Par Value | 6,300 | $21.71 | $136,773.00 |
DisclosureSEC source: 0001415889-20-001489 · form4-06032020_020658.xml · nonDerivative · entry 1 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.